Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)

Avalo Therapeutics (AVTX) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio fell 80.76% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2025, down 80.76%, and an annual FY2024 reading of 0.01, down 92.74% over the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2025 at Avalo Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.56 in Q2 2023 and bottomed at 0.0 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.15, with a median of 0.08 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 739.91% in 2022, then tumbled 98.76% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.06 in 2021, then surged by 739.91% to 0.52 in 2022, then crashed by 85.17% to 0.08 in 2023, then plummeted by 95.38% to 0.0 in 2024, then crashed by 56.89% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for AVTX at 0.0 in Q3 2025, 0.0 in Q2 2025, and 0.0 in Q1 2025.